Thrombophilia: Difference between revisions
mNo edit summary |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombophilia}} | {{Thrombophilia}} | ||
{{CMG}} {{AE}} [[User:Kashish Goel|Kashish Goel, M.D.]], {{asiri}} | {{CMG}}; {{AE}} [[User:Kashish Goel|Kashish Goel, M.D.]], {{asiri}},{{M.B}}, {{MKA}}, {{S.G.}}, {{JK}} | ||
{{SK}} Hypercoagulability, coagulability, hypercoagulable state; thrombosis risk elevation; thrombotic tendency; prothrombotic state; clotting disorder; | {{SK}} Hypercoagulability, coagulability, hypercoagulable state; thrombosis risk elevation; thrombotic tendency; prothrombotic state; clotting disorder; |
Latest revision as of 07:24, 15 March 2021
Thrombophilia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombophilia On the Web |
American Roentgen Ray Society Images of Thrombophilia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kashish Goel, M.D., Asiri Ediriwickrema, M.D., M.H.S. [2],Mohsen Basiri M.D., M. Khurram Afzal, MD [3], Sogand Goudarzi, MD [4], Jaspinder Kaur, MBBS[5]
Synonyms and keywords: Hypercoagulability, coagulability, hypercoagulable state; thrombosis risk elevation; thrombotic tendency; prothrombotic state; clotting disorder;
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thrombophilia from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Studies | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies | Cost Effectiveness of Therapy